指南与共识医学教育与科研方法流行病学与生物统计

指南制定组织指导文件第10篇:制定关于诊断性检测及策略的推荐意见

Guideline organizations' guidance documents paper 10: developing recommendations about diagnostic tests and strategies.
指南 / 共识 · J Clin Epidemiol · 2025-11-19

该研究对指南制定组织的指导文件进行描述性汇总,从133个组织中识别出44个(33%)在文件中描述了制定诊断性检测及策略推荐意见的流程,多数为专业组织(52%)且为国家层面(80%)。最常涉及的主题是「判断证据质量、强度或确定性」(55%)和「问题生成」(32%),另有多个主题未被任何组织涉及。作者结论认为仅少数组织提及针对诊断性检测的特定流程,需进一步细化相关指导。

要点

  • 133个指南制定组织中仅44个(33%)指导文件描述了诊断性检测推荐意见的制定流程。
  • 最常涉及主题为判断证据质量、强度或确定性(55%)和问题生成(32%)。
  • 指南小组流程、目标受众与选题、利益相关方参与、利益冲突、传播实施及更新等主题未被任何组织涉及。

核心结论

  • 少数指南制定组织的指导文件提及了制定诊断性检测及策略推荐意见的特定流程。
  • 需要进一步细化针对诊断性检测的指导,以改进实践指南制定流程。

研究设计与样本

  • 对指南制定组织的指导文件进行描述性汇总。
  • 通过不同来源汇编合格组织名单并检索其关于实践指南制定的指导文件,由两名作者独立重复筛选组织和文件。
  • 从133个指南制定组织中识别出44个(33%)在指导文件中描述了制定诊断性检测及策略推荐意见的流程。

主要发现

  • 44个组织多数为专业组织(52%)且为国家层面(80%)。
  • 提供诊断性检测及策略特定指导的主题数中位数为1(范围=1-5)。
  • 最常涉及的主题为「判断证据质量、强度或确定性」(55%)和「问题生成」(32%)。
  • 未被任何组织涉及的主题包括「建立指南小组流程」、「确定目标受众与选题」、「消费者与利益相关方参与」、「利益冲突考量」、「传播与实施」及「更新」。

关键数值与推荐

  • 在133个指南制定组织中,44个(33%)描述了制定诊断性检测及策略推荐意见的流程。
  • 最常涉及主题为「判断证据质量、强度或确定性」(55%)和「问题生成」(32%)。
  • 提供诊断性检测特定指导的主题数中位数为1(范围=1-5)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Diagnostic tests are central to clinical decision-making, but the rigor and consistency of guidelines that inform their use remain unclear. This study aimed to describe processes for developing recommendations about diagnostic tests and strategies as outlined in guidance documents of guideline-producing organizations. METHODS: We conducted a descriptive summary of guidance documents from guideline-producing organizations. We first compiled a list of eligible organizations using different sources and retrieved their guidance documents on practice guideline development. Two authors screened organizations and their documents in duplicate and independently. We abstracted information on whether organizations provided guidance on developing recommendations about diagnostic tests and strategies for each of the Guideline International Network McMaster Guideline Development Checklist topics and their corresponding details. RESULTS: Out of 133 guideline-producing organizations identified, 44 (33%) described processes for developing recommendations about diagnostic tests and strategies in their guidance documents. The majority of these organizations were professional (52%) and were at the national level (80%). The median number of topics for which guidance specific to diagnostic tests and strategies was provided was 1 (range = 1-5). The topics most frequently addressed were "judging the quality, strength, or certainty of evidence" (55%) and "question generation" (32%). Topics not addressed by any organization were "establishing guideline group processes," "identifying target audience and topic selection," "consumer and stakeholder involvement, " "conflict of interest considerations," "dissemination and implementation," and "updating." CONCLUSION: A minority of guideline-producing organizations' guidance documents mentioned specific processes for developing recommendations for diagnostic tests and strategies. Further refinement of guidance tailored to diagnostic tests is needed to improve practice guideline development processes.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Helou V, Basbous L, Mustafa RA, et al. Guideline organizations' guidance documents paper 10: developing recommendations about diagnostic tests and strategies. J Clin Epidemiol. 2025. PMID: 41270891. doi:10.1016/j.jclinepi.2025.112068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。